Is Keflex (cephalexin) appropriate for treating an acute bacterial sinus infection?

Keflex is NOT appropriate for treating acute bacterial sinus infections

Keflex (cephalexin) should not be used as first-line therapy for acute bacterial sinusitis because it is a first-generation cephalosporin with inadequate coverage against the primary pathogens responsible for this infection.

Why Keflex Fails for Sinus Infections

The most authoritative guidelines consistently identify the same bacterial culprits in acute bacterial sinusitis:

• Streptococcus pneumoniae
• Haemophilus influenzae (50% produce β-lactamase)
• Moraxella catarrhalis (90-100% produce β-lactamase)

First-generation cephalosporins like cephalexin and cefadroxil have poor coverage for H. influenzae and are therefore inappropriate for sinusitis 1. This is explicitly stated in the 2005 practice parameter: these agents "have the disadvantage of poor coverage for H influenzae and are therefore inappropriate" 1.

What You Should Prescribe Instead

First-Line Therapy

Amoxicillin with or without clavulanate is the recommended first-line treatment 2, 3, 4, 3:

• Standard-dose amoxicillin (45 mg/kg/day divided twice daily; adult: 500 mg BID) for:

  • Children ≥2 years old
  • No daycare attendance
  • No antibiotics in past 30 days
  • Mild-to-moderate illness

• High-dose amoxicillin-clavulanate (80-90 mg/kg/day of amoxicillin component; adult: 875 mg BID) for:

  • Children <2 years old
  • Daycare attendance
  • Recent antibiotic use (within 30 days)
  • Moderate-to-severe illness (fever ≥39°C with purulent discharge)
  • Geographic areas with >10% penicillin-resistant S. pneumoniae 3

For Penicillin Allergy

If true penicillin allergy exists, use second- or third-generation cephalosporins 2, 3:

• Cefdinir
• Cefuroxime
• Cefpodoxime

Important caveat: Recent evidence shows the risk of cross-reactivity between penicillins and second/third-generation cephalosporins is "almost nil" 3. The R1 side chain structure differs significantly from penicillins, reducing cross-allergy risk 5.

Treatment Duration

Treat for 10-14 days, or alternatively for 7 days after symptom resolution 1, 3. This individualized approach ensures at least 10 days of therapy while avoiding unnecessary treatment in asymptomatic patients.

Shorter courses (5-7 days) may be equally effective based on meta-analysis data 6, but the established guidelines support the 10-14 day standard.

When to Reassess

Reassess at 72 hours if the patient reports worsening symptoms or failure to improve 3. At this point, either change antibiotics or consider that the diagnosis may be viral rather than bacterial.

Critical Diagnostic Criteria

Only treat with antibiotics when acute bacterial sinusitis is diagnosed by one of three presentations 3, 4:

1. Persistent: Nasal discharge or cough >10 days without improvement
2. Worsening: New/worsening fever, discharge, or cough after initial improvement
3. Severe: Fever ≥39°C + purulent discharge for ≥3 consecutive days

The Bottom Line

The FDA label for Keflex 7 warns that "prescribing Keflex in the absence of a proven or strongly suspected bacterial infection...is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria." While older studies from the 1980s-1990s 8, 9 showed some efficacy with cephalexin, current evidence-based guidelines uniformly exclude first-generation cephalosporins from recommended regimens due to inadequate H. influenzae coverage.

Use amoxicillin ± clavulanate as your first-line agent, adjusting the dose based on patient risk factors and local resistance patterns.